GENERAL ASSEMBLY

JOINT COMMITTEE ON
BEHAVIORAL HEALTH & OPIOID USE DISORDERS

Antonio L. Hayes, Senate Chair (chosen by Senate President) (410) 841-3656, (301) 858-3656
Kirill Reznik, House Chair (chosen by House Speaker) (410) 841-3039, (301) 858-3039

Staff: Erin R. Hopwood; e-mail: erin.hopwood@mlis.state.md.us
David A. Smulski; e-mail: david.smulski@mlis.state.md.us

c/o Department of Legislative Services
Legislative Services Building, 90 State Circle, Annapolis, MD 21401
(410) 946-5350, (301) 970-5350; 1-800-492-7122, ext. 5350 (toll free)

In June 2015, the Joint Committee on Behavioral Health and Opioid Use Disorders was authorized (Chapter 464, Acts of 2015).

The Committee oversees the Prescription-Drug Monitoring Program, and State and local programs to treat and reduce behavioral health and opioid use disorders. The Committee also is to review the final report of the Governor's Heroin and Opioid Emergency Task Force, and review and monitor the work of the Governor's Inter-Agency Heroin and Opioid Coordinating Council.

Ten members constitute the Committee: five senators appointed by the Senate President and five delegates appointed by the House Speaker (Code State Government Article, sec. 2-10A-02).

Senate
House of Delegates
General Assembly
Legislative Committees
Legislative Process
Maryland Government
Maryland Constitutional Offices & Agencies
Maryland Departments
Maryland Independent Agencies
Maryland Executive Commissions, Committees, Task Forces, Advisory Boards
Maryland Universities & Colleges
Maryland Counties
Maryland Municipalities
Maryland at a Glance


Maryland Manual On-Line

© Copyright Maryland State Archives